Eyestem will be presenting its data at the ARVO 2025 Annual Meeting as well as the 10th Retinal Cell and Gene Therapy ...

A novel DIPN method enhances GA segmentation by integrating ConvLSTM, projection attention, adaptive pooling, and contrastive ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness ...

A cell-based subretinal implant shows promise in the treatment of geographic atrophy, achieving the unprecedented milestone ...

Bilco from Yarmouth Greyhound Rehoming faces daily battles due to a genetic disease called Progressive Retinal Atrophy (PRA).

Javed Shaikh, Director of RWE & HEOR, Axtria, explains how harnessing next-generation sequencing and AI-powered analytics ...

The global Age-Related Macular Degeneration (AMD) Market is poised for significant expansion over the next decade, with its value expected to grow from US$ 11.31 billion in 2023 to US$ 19.72 billion ...

Hear the story of Yves Daniel whose journey with Geographic Atrophy (GA) reveals daily challenges and unwavering resilience. His hope for future treatments underscores the urgent need for increased ...

Ex-Intel head says TSMC’s new investment will not resurrect US chip sector A link to the live and archived webcast may be accessed on the Clearside website under the Investors section: Events and ...

Spinal muscular atrophy (SMA) is a disorder affecting the motor neurons—nerve cells that control voluntary muscle movement. These cells are located in the spinal cord. Because the muscles cannot ...

With companies around the globe working to development new candidates for treating patients with retinal diseases ... is intended for the treatment of vision loss due to geographic atrophy (GA) ...

The primary endpoint was a composite of incident cases of AMD plus cases of progression to advanced AMD (geographic atrophy, neovascular membrane, retinal pigment epithelium detachment, or disciform ...